Company: SVV
Filing Date: 2025-05-13
Form Type: S-3
Source: 0001193125-25-118371
Chunk: 40

Company: Savers Value Village, Inc.
Filing Date: 2025-05-13
Form: S-3
Chunk 40
---
 common stock. As a result, purchasers of shares of common stock in this offering bear the risk that future issuances of equity securities may reduce the value of their shares and dilute their ownership interests. Also, to the
extent outstanding stock-based awards are issued or become vested, there will be further dilution to the holders of our common stock.

Our reliance on dividends, distributions and other payments from our subsidiaries to meet our obligations.

We are a holding company that does not conduct any business operations of our own. As a result, we are dependent upon cash distributions and
other transfers from our subsidiaries to meet our obligations. Each of our subsidiaries is a distinct legal entity, and under certain circumstances legal and contractual restrictions may limit

S-8

our ability to obtain cash from them. The deterioration of the earnings from, or other available assets of, our subsidiaries for any reason could impair their ability to make distributions to us. The Ares Funds, whose interests may conflict with our interests and those of other stockholders, will continue to control our Company after this offering, including having the right to designate nominees for election to our board of directors, and may have interests that conflict with our interests and those of other stockholders. As such, the Ares Funds will be able to continue to influence or control our affairs and policies following the completion of this offering (including the Concurrent Share Repurchase). Following this offering and the Concurrent Share Repurchase, the Ares Funds will beneficially own 76.89% of our common stock (or 75.45% if the underwriters exercise their option to purchase additional shares in full). Pursuant to that certain stockholders agreement entered into between the Ares Funds and us, dated as of July 3, 2023 (the “Stockholders Agreement”), for so long as the Ares Funds hold 5% or more of our outstanding common stock, they have the right to designate a certain number of individuals to be included in the slate of nominees for election to our board of directors and to designate a member of each committee of the board of directors. Further, for so long as the Ares Funds own 40% or more of our outstanding common stock, the Ares Funds can designate at least a majority of our board of directors. Additionally, because our board of directors is divided into three staggered classes, the Ares Funds may be able to influence or control our affairs and policies for a period of time after such rights expire, while their nominees finish their terms as members of our board